TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
Titel:
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial
Auteur:
Quoix, Elisabeth Lena, Hervé Losonczy, Gyorgy Forget, Frédéric Chouaid, Christos Papai, Zsolt Gervais, Radj Ottensmeier, Christian Szczesna, Aleksandra Kazarnowicz, Andrzej Beck, Joseph T Westeel, Virginie Felip, Enriqueta Debieuvre, Didier Madroszyk, Anne Adam, Julien Lacoste, Gisèle Tavernaro, Annette Bastien, Bérangère Halluard, Céline Palanché, Tania Limacher, Jean-Marc